Follow
Martin L Miller
Martin L Miller
Senior Director, AstraZeneca
Verified email at astrazeneca.com
Title
Cited by
Cited by
Year
Mutational landscape determines sensitivity to PD-1 blockade in non–small cell lung cancer
NA Rizvi, MD Hellmann, A Snyder, P Kvistborg, V Makarov, JJ Havel, ...
Science 348 (6230), 124-128, 2015
63562015
The cancer genome atlas pan-cancer analysis project
JN Weinstein, EA Collisson, GB Mills, KR Shaw, BA Ozenberger, K Ellrott, ...
Nature genetics 45 (10), 1113-1120, 2013
49612013
Genomic classification of cutaneous melanoma
R Akbani, KC Akdemir, BA Aksoy, M Albert, A Ally, SB Amin, H Arachchi, ...
Cell 161 (7), 1681-1696, 2015
19492015
Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis
MM Jesper V Olsen, Michiel Vermeulen, Anna Santamaria, Chanchal Kumar ...
Science Signaling, 2010
15022010
Emerging landscape of oncogenic signatures across human cancers
G Ciriello, ML Miller, BA Aksoy, Y Senbabaoglu, N Schultz, C Sander
Nature genetics 45 (10), 1127-1133, 2013
12532013
Transfection of small RNAs globally perturbs gene regulation by endogenous microRNAs
AA Khan, D Betel, ML Miller, C Sander, CS Leslie, DS Marks
Nature biotechnology 27 (6), 549-555, 2009
5642009
Linear motif atlas for phosphorylation-dependent signaling.
ML Miller, LJ Jensen, F Diella, C Jørgensen, M Tinti, L Li, M Hsiung, ...
Science signaling 1 (35), ra2, 2008
4752008
Heterogeneous tumor-immune microenvironments among differentially growing metastases in an ovarian cancer patient
A Jiménez-Sánchez, D Memon, S Pourpe, H Veeraraghavan, Y Li, ...
Cell 170 (5), 927-938. e20, 2017
3382017
Mitochondrial DNA copy number variation across human cancers
E Reznik, ML Miller, Y Şenbabaoğlu, N Riaz, J Sarungbam, SK Tickoo, ...
elife 5, e10769, 2016
3112016
KinomeXplorer: an integrated platform for kinome biology studies
H Horn, EM Schoof, J Kim, X Robin, ML Miller, F Diella, A Palma, ...
Nature methods 11 (6), 603-604, 2014
2712014
UVB-induced tumor heterogeneity diminishes immune response in melanoma
Y Wolf, O Bartok, S Patkar, GB Eli, S Cohen, K Litchfield, R Levy, ...
Cell 179 (1), 219-235. e21, 2019
1752019
NetPhosYeast: prediction of protein phosphorylation sites in yeast
CR Ingrell, ML Miller, ON Jensen, N Blom
Bioinformatics 23 (7), 895-897, 2007
1512007
Perturbation biology: inferring signaling networks in cellular systems
EJ Molinelli, A Korkut, W Wang, ML Miller, NP Gauthier, X Jing, P Kaushik, ...
PLoS computational biology 9 (12), e1003290, 2013
1352013
The SH2 domain interaction landscape
M Tinti, L Kiemer, S Costa, ML Miller, F Sacco, JV Olsen, M Carducci, ...
Cell reports 3 (4), 1293-1305, 2013
1092013
Pan-cancer analysis of mutation hotspots in protein domains
ML Miller, E Reznik, NP Gauthier, BA Aksoy, A Korkut, J Gao, G Ciriello, ...
Cell systems 1 (3), 197-209, 2015
922015
Drug synergy screen and network modeling in dedifferentiated liposarcoma identifies CDK4 and IGF1R as synergistic drug targets
ML Miller, EJ Molinelli, JS Nair, T Sheikh, R Samy, X Jing, Q He, A Korkut, ...
Science signaling 6 (294), ra85-ra85, 2013
842013
Unraveling tumor–immune heterogeneity in advanced ovarian cancer uncovers immunogenic effect of chemotherapy
A Jiménez-Sánchez, P Cybulska, KLV Mager, S Koplev, O Cast, ...
Nature genetics 52 (6), 582-593, 2020
772020
NetPhosBac–a predictor for Ser/Thr phosphorylation sites in bacterial proteins
ML Miller, B Soufi, C Jers, N Blom, B Macek, I Mijakovic
Proteomics 9 (1), 116-125, 2009
692009
Kinase-specific prediction of protein phosphorylation sites
ML Miller, N Blom
Phospho-Proteomics, 299-310, 2009
672009
Integrin-α10 dependency identifies RAC and RICTOR as therapeutic targets in high-grade myxofibrosarcoma
T Okada, AY Lee, LX Qin, N Agaram, T Mimae, Y Shen, R O'Connor, ...
Cancer discovery 6 (10), 1148-1165, 2016
492016
The system can't perform the operation now. Try again later.
Articles 1–20